ArticleCancers2021

A Targeted-Covalent Inhibitor of 17β-HSD1 Blocks Two Estrogen-Biosynthesis Pathways: In Vitro (Metabolism) and In Vivo (Xenograft) Studies in T-47D Breast Cancer Models.

Donald Poirier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.